Skip to content

Saliva for Assessment of Vitamin A status in preterm Infants

Vitamin A status assessment using saliva versus blood in preterm infants.

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000658516
Acronym
SAVIng blood
Enrollment
30
Registered
2015-06-25
Start date
2015-09-01
Completion date
2015-11-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Background: Vitamin A is essential for development and growth of lungs in preterm infants. Diseases characterised by abnormal lung development such as bronchopulmonary dysplasia (BPD) may be linked to vitamin A deficiency. BPD is associated with long term breathing and developmental problems. Very preterm infants are at risk of vitamin A deficiency. Timely evaluation of vitamin A status of preterm infants may help to assess the risk of BPD and tailor vitamin A therapy based on the infant’s vitamin A status. Current method of assessment of vitamin A is “Relative Dose Response” (RDR). RDR test involves collection of two blood samples from the infant, one before and one after a dose of vitamin A. Thus, the requirement of repeated blood sampling, which is an invasive procedure and also increases risk of anaemia, is a major disadvantage of current RDR test. Therefore, a minimally invasive method with least harm is required. Aim: 1) To compare salivary vitamin A with blood vitamin A, and RDR using saliva with RDR using blood; 2) Assess safety of the test Participant group: Participants will be preterm infants admitted in King Edward Memorial Hospital, less than 30 weeks gestational age at birth and 21 to 28 days of life, and tolerating milk feeds. Project design and Methods: An informed consent will be obtained from the parents of the eligible infants. RDR test will be performed. The test involves collection of blood samples of 0.5 mL each, before and five hours after a dose of vitamin A (2000 IU/kg body weight). Along with the blood samples, samples of saliva will also be collected using proprietary swab specifically designed for infants. An additional saliva sample will be collected at seven hours, as appearance of vitamin A in saliva may lag behind its appearance in blood. Collection of saliva is a painless procedure with no expected harm to the infant. Vitamin A levels will be measured in blood and saliva samples with high performance liquid chromatography which is a standard method of vitamin A measurement. All the study infants will be monitored for 24 hours for adverse effect of vitamin A. Expected outcomes: A study in adults showed a good correlation between salivary and blood vitamin A in adults. We expect that salivary vitamin A level will correlate with blood vitamin A in preterm infants and will be useful to assess vitamin A status of preterm infant

Interventions

The Relative Dose Response (RDR) test will be performed to assess vitamin A status. The test involves collection of blood samples of 0.5 mL each, before and five hours after a dose of vitamin A [Vitamin A Nepalm (Registered Trademark)] (Dose: 2000 IU/kg body weight) orally in a liquid solution form. In addition to the blood samples, samples of saliva will be collected using a proprietary swab specifically designed for newborn infants [Saliva Bio Infants's Swab; Salimetrics (Registered Trademark)

The Relative Dose Response (RDR) test will be performed to assess vitamin A status. The test involves collection of blood samples of 0.5 mL each, before and five hours after a dose of vitamin A [Vitamin A Nepalm (Registered Trademark)] (Dose: 2000 IU/kg body weight) orally in a liquid solution form. In addition to the blood samples, samples of saliva will be collected using a proprietary swab specifically designed for newborn infants [Saliva Bio Infants's Swab; Salimetrics (Registered Trademark) USA]. An additional saliva sample will be collected at seven hours, as appearance of vitamin A in saliva may lag behind its appearance in blood. Collection of saliva is a painless procedure with no expected harm to the infant. Vitamin A levels will be measured in blood and saliva samples with high performance liquid chromatography which is a standard method of vitamin A measurement.

Sponsors

Women and Infants Research Foundation
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
21 Days to 35 Days
Healthy volunteers
No

Inclusion criteria

1. Preterm infants less than 30 weeks gestational age at birth. 2. Infants tolerating enteral feeds. 3. 21 to 35 days of age

Exclusion criteria

1. Infants with necrotizing enterocolitis or major congenital gastrointestinal malformation. 2. Critically unwell infants. 3. Systemic administration of corticosteroids within seven days prior to the test. 4. No parental consent.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026